Cell Therapies
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
46
NCT05237206
Study of SUPLEXA in Patients With Metastatic Solid Tumours and Haematologic Malignancies
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 28, 2022
Completion: Jul 23, 2024
Loading map...